`Mythbuster’ Cheskin on Powervision’s Future Pipeline, Strength of IOLs



Barry Cheskin, Co-Founder, President & CEO of PowerVision, introduces the company’s next iteration, Fluidvision 2020, a new IOL that doubles the power of accomodation for patients. Powervision expects to have the IOL in clinics next year. Citing Powervision clinical data, he also busts a myth about IOLs lifetime in the lens capsule.

Read More on this interview:

`Mythbuster’ Cheskin on Powervision’s Future Pipeline, Strength of IOLs

Check out our Eye On Innovation Newsletter to keep up with Innovation & Investing in Ophthalmology – Updated Every Week!
http://ois.net/eye-on-innovation/

Source

Do you love us?, Please donate to us ,thank you. BTC 38WPVc3xMYmoMp1GcnpDXd1fEzbfgujsCB Etherum 0x6c11844FD079b2490CDd44039e1C2f0940d098dc

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.